PyInvesting

Market research

MBW.F Medical & Biological Laboratories Co., Ltd

F EUR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
179M
P/E ratio
138.84
Analyst target
Not available
Dividend yield
0.0%
Beta
0.67

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Medical & Biological Laboratories Co., Ltd is currently in a long term downtrend where the price is trading 55.8% below its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.

Medical & Biological Laboratories Co., Ltd's total revenue rose by 19.6% to $3B since the same quarter in the previous year.

Its net income has increased by 137.9% to $596M since the same quarter in the previous year.

Based on the above factors, Medical & Biological Laboratories Co., Ltd gets an overall score of 3/5.